NF1
Clinical trials for NF1 explained in plain language.
Never miss a new study
Get alerted when new NF1 trials appear
Sign up with your email to follow new studies for NF1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with untreatable tumors
Disease control OngoingThis study tested an oral drug called selumetinib for children and young adults with neurofibromatosis type 1 (NF1) who have nerve tumors that cannot be removed by surgery. The main goals were to find a safe dose and see if the drug could shrink or stop these tumors from growing.…
Matched conditions: NF1
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Blood test breakthrough could replace scans for NF1 tumor tracking
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to find signals in the blood that can tell doctors about tumor growth in people with Neurofibromatosis type 1 (NF1). Researchers will study 200 people with NF1, using blood tests and full-body MRI scans to see if specific blood markers match the size and number of…
Matched conditions: NF1
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:14 UTC